导师基本信息
- 姓名：朱旭
- 性别：男
- 民族：汉族
- 科室：介入治疗科
- 职称：主任医师,教授
- 专业：肿瘤学、肿瘤内科学
- E-MAIL： drzhuxu@163.com
学术论文 | 综述述评 | 出版专著 | 奖励表彰 | 研究方向 | 科研项目 | 招生计划
Baojiang Liu#; Song Gao#; Jianhai Guo; Fuxin Kou; Shaoxing Liu; Xin Zhang; Aiwei Feng; Xiaodong Wang; Guang Cao; Liang Xu; Hui Chen; Peng Liu; Haifeng Xu; Qinzong Gao; Renjie Yang; Xu Zhu*; High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy,International Immunopharmacology,2024, 130(2024-3): 1567-5769
56. Baojiang Liu; Song Gao; Jianhai Guo; Fuxin Kou; Shaoxing Liu; Xin Zhang; Aiwei Feng; Xiaodong Wang; Guang Cao; Liang Xu; Hui Chen; Peng Liu; Haifeng Xu; Qinzong Gao; Renjie Yang; Xu Zhu*; Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma,J Hepatocell Carcinoma,4:11:477-488.
Liu B#, Gao S#, Guo J, Kou F, Liu S, Zhang X, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Zhu X*A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy.,Transl Oncol,
Bao-jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma.,World gastrointestinal oncology,12(6):12-20
Qian Liang#, Lingxin Kong#, Xu Zhu*, Yang Du*, Jie Tian*. Noninvasive Imaging for Assessment ofthe Efficacy of Therapeutic Agents for Hepatocellular Carcinoma,Mol ImagingBiol,(2019)51:76
Kanglian Zheng#, Xu Zhu#, Shijie Fu, Guang Cao, Wen-Qing Li, Liang Xu, HuiChen, DiWu, RenjieYang, KunWang, WeiLiu, HongweiWang, Quan Bao, Ming Liu, Chunyi Hao, Lin Shen, Baocai Xing, Xiaodong Wang*, Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.,Radiology,303:455–464
徐海峰,朱旭,陈辉,刘鹏,高钦宗.肾部分切除术后出血的数字减影血管造影 表现及介入治疗疗效分析,中华医学杂志,101(11)
Kou Fuxin, Gao Song, Liu Shaoxing, Wang Xiaodong, Chen Hui, Zhu Xu, Guo Jianhai, Zhang Xin, Feng Aiwei, Liu Baojiang. Preliminary clinical efficacy of iodine-125 seed implantation for the treatment of advanced malignant lung tumors.,J Cancer Res Ther,15(7): 1567-1573.
Guo JH#, Liu SX#, Gao S#, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu Peng, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, Zhu X*. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma.,World J Gastroenterol,2020;26(27):3975-3988.
刘少兴,朱旭. 肝动脉灌注化疗治疗中晚期肝癌研究进展,中国介入影像与治疗学,2020 oct 10 ;17(10):632-635。
Guo J#, Liu S#, Gao S, Kou F, Zhang X, Liu P, Yang R, Zhu X*.γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.,J Vasc Interv Radiol,S1051-0443(20)30605-9
Guo J#, Liu S#, Gao S, Kou F, Zhang X, Liu P, Yang R, Zhu X*.γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.,J Vasc Interv Radiol,S1051-0443(20)30605-9
郭建海,朱旭*.晚期原发性肝癌的肝动脉灌注化疗.,肝癌电子杂志,6(04):20-23
曹广,朱旭*.结直肠癌肝转移介入治疗联合瑞戈非尼病例分享及思考,肝癌电子杂志,6(04):39-42
Guo JH#, Liu SX#, Gao S#, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu Peng, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, Zhu X*. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma.,World J Gastroenterol,2020;26(27):3975-3988.
Bao-Jiang Liu, Song Gao, Xu Zhu* , Jian-Hai Guo, Fu-Xin Kou, Shao-Xing Liu , Xin Zhang , Xiao-Dong Wang, Guang Cao , Hui Chen , Peng Liu , Lin-Zhong Zhu , Hai-Feng Xu , and Ren-Jie Yang. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.,BioMed Research International.,2021:6670367.
Liu BJ#, Gao S, Zhu X*, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Xu HF, Gao QZ, Yang RJ. Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma.,Immunotherapy,13(17):1395-1405.
Guang Cao*, Xiaodong Wang, Hui Chen, Song Gao, Jianhai Guo, Peng Liu, Haifeng Xu, Liang Xu, Xu Zhu* and Renjie Yang. Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study.,BMC Gastroenterology,(2022) 22:328.
Feng AW, Guo JH, Gao S, Kou FX, Liu SX, Liu P, Chen H, Wang XD, Xu HF, Cao G, Zhu X*. A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases.,Front Oncol.,21;12:913017.
曹广,朱旭*.结直肠癌肝转移介入治疗联合瑞戈非尼病例分享及思考,肝癌电子杂志,6(04):39-42
郭建海,朱旭*.晚期原发性肝癌的肝动脉灌注化疗,肝癌电子杂志,6(04):20-23.
《介入放射学》, 参编, 人民卫生出版社, 2022.5
“登峰”人才培养计划, “登峰”人才培养计划, 第1完成人, 北京市医院管理中心, 2022.7
基于多组学的多纳非尼在肝细胞癌中的耐药机制研究及临床应用研究, 课题负责人, 2024.1.1～2027.12.17, 国家自然科学基金面上项目
肿瘤微创介入治疗, 课题负责人, 2023.1.3～2026.12.31, 北京市医院管理中心“登峰”人才培养计划
国产创新肿瘤复合式冷热消融系统应用示范研究项目——肿瘤复合式冷热消融应用示范共性技术研究与产品评价体系建设课题, 课题负责人, 2023.11.1～2026.10.31, 国家重点研发计划——诊疗装备与生物医用材料专项
基于多模态影像组学和人工智能建立肝动脉灌注化疗晚期结直肠癌肝转移疗效评价模型及临床价值评估, 课题负责人, 2020.1.1～2023.12.31, 国家自然科学基金面上项目
肝肺肿瘤微创介入—冷冻消融应用示范及其支撑技术规范化应用研究, 课题负责人, 2019.1.31～2020.7.31, 北京市科委配套资金（2017年度国家重点研发计划）
肝肺肿瘤微创介入—冷冻消融应用示范及其支撑技术规范化应用研究, 课题负责人, 2017.7.31～2020.6.30, 2017年度国家重点研发计划—高端诊疗装备区域应用示范:2017YFC0114004
2015年度国家自然科学基金面上项目：FOXB2和DBX2 在原发性肝细胞癌发生发展分子机制及临床价值的研究, 课题负责人, 2016.1.1～2019.12.30, 2015年度国家自然科学基金面上项目:81571781
cTACE or DEB-TACE+HAIC联合瑞戈非尼±抗PD-1 单抗治疗不可切除肝细胞癌的真实世界研究, 课题负责人, 2020.6.1～2023.5.1, 希思科-拜耳肿瘤研究基金
Mucin-1介导肝内胆管癌EMT的作用机制及介入治疗预后关联研究, 课题负责人, 2023.1.1～2025.12.31, 北京市自然科学基金面上项目
肝动脉持续灌注化疗联合替雷利珠单抗及瑞戈非尼用于晚期经治的结直肠癌肝转移患者的安全性、开放、单中心临床研究, 课题负责人, 2021.12.1～2024.6.30, 北京癌症防治学会“癌症预防与诊治科研基金”
社会任职
- 北京癌症防治学会肝癌微创介入治疗专委会主任委员
- 北京市抗癌协会肿瘤介入专业委员会副主任委员
- 中华医学会放射学分会介入学组委员
- 肿瘤冷消融技术创新中心主任委员
